Radiation Lobectomy-A Minimally Invasive Treatment Model for Liver Cancer: Case Report

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 5, 2009, Pages 664-669

  Siddiqi, Nasir H ^a   Devlin, Phillip M ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; ERLOTINIB; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; YTTRIUM 90;

AGED; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CANCER; LIVER LOBECTOMY; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIOSURGERY;

AGED; CARCINOMA; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 64849098612     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.01.023     Document Type: Article

References (15)

1. Kennedy A., Nag S., Salem R., et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68 (2007) 13-23
2. Lewandowski R, Salem R, Thurston K, et al. Radiation segmentectomy of unresectable of liver carcinoma using selective infusion of intraarterial yttrium-90 TheraSphere. Presented at the Radiological Society of North America; November 28 to December 3, 2004; Chicago, IL.
3. Greene F.L., Page D.L., and Fleming I.D. AJCC Cancer Staging Manual (2002), Springer, New York
4. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
5. Murthy R., Nunez R., Szklaruk J., et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25 suppl 1 (2005) S41-S55
6. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
7. Bentrem D.J., Dematteo R.P., and Blumgart L.H. Surgical therapy for metastatic disease to the liver. Annu Rev Med 56 (2005) 139-156
8. Liu J.H., Chen P.W., Asch S.M., Busuttil R.W., and Ko C.Y. Surgery for hepatocellular carcinoma: does it improve survival?. Ann Surg Oncol 11 (2004) 298-303
9. Wolpin B.M., Meyerhardt J.A., Mamon H.J., and Mayer R.J. Adjuvant treatment of colorectal cancer. CA Cancer J Clin 57 (2007) 168-185
10. Taieb J., Barbare J.C., and Rougier P. Medical treatments for hepatocellular carcinoma (HCC): what's next?. Ann Oncol 17 suppl 10 (2006) 308-314
11. Garrean S., Hering J., Helton W.S., and Espat N.J. A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors. Am J Surg 194 (2007) 79-88
12. Dawson L.A. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma. J Vasc Interv Radiol 16 (2005) 161-164
13. Lien W.M., and Ackerman N.B. The blood supply of experimental liver metastases. II: a microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery 68 (1970) 334-340
14. Kennedy A.S., Nutting C., Coldwell D., Gaiser J., and Drachenberg C. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60 (2004) 1552-1563
15. Hemming A.W., Reed A.I., Howard R.J., et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237 (2003) 686-691